List of works - Mar Gil

Analysis of Cell-Free DNA in Maternal Blood in Screening For Aneuploidies: Updated Meta-Analysis.

scientific article

Analysis of cell-free DNA in maternal blood in screening for aneuploidies: meta-analysis.

scientific article published on January 2014

Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis

scientific article published on February 2015

Assessment of fetal sex chromosome aneuploidy using directed cell-free DNA analysis.

scientific article published on 11 December 2013

Classification of Uterine Anomalies by 3-Dimensional Ultrasonography Using ESHRE/ESGE Criteria: Interobserver Variability.

scientific article

Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.

scientific article published on 26 October 2015

Effects of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcomes: a systematic review

scientific article published on 19 May 2020

First-trimester contingent screening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testing.

scientific article

First-trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure

scientific article published on 01 June 2019

Genome-wide cfDNA testing of maternal blood

scientific article published on 01 January 2020

Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies.

scientific article published on 7 June 2013

Performance of screening for aneuploidies by cell-free DNA analysis of maternal blood in twin pregnancies

scientific article published on 04 December 2014

Reply

Risk of miscarriage after chorionic villus sampling

scientific article published on 12 April 2020

Routine first-trimester screening for fetal trisomies in twin pregnancies: cell-free DNA test contingent on results from the combined test

article

Screening for trisomies 21 and 18 in a Spanish public hospital: from the combined test to the cell-free DNA test

scientific article published on 2 November 2016

Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10-11 weeks' gestation and the combined test at 11-13 weeks

scientific article published on 20 November 2014

Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy: update of The Fetal Medicine Foundation results and meta-analysis

scientific article published on 04 June 2019

The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled Trial

scientific article published in 2022

UK NHS pilot study on cell-free DNA testing in screening for fetal trisomies: factors affecting uptake.

scientific article published on 24 November 2014

Use of intrapartum ultrasound in the prediction of complicated operative forceps delivery of fetuses in non-occiput posterior position

scientific article published on 01 June 2014

Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y.

scientific article published on 24 April 2013

List of works by Mar Gil

Analysis of Cell-Free DNA in Maternal Blood in Screening For Aneuploidies: Updated Meta-Analysis.

Analysis of cell-free DNA in maternal blood in screening for aneuploidies: meta-analysis.

Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis

Assessment of fetal sex chromosome aneuploidy using directed cell-free DNA analysis.

Classification of Uterine Anomalies by 3-Dimensional Ultrasonography Using ESHRE/ESGE Criteria: Interobserver Variability.

Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.

Effects of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcomes: a systematic review

First-trimester contingent screening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testing.

First-trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure

Genome-wide cfDNA testing of maternal blood

Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies.

Performance of screening for aneuploidies by cell-free DNA analysis of maternal blood in twin pregnancies

Reply

Risk of miscarriage after chorionic villus sampling

Routine first-trimester screening for fetal trisomies in twin pregnancies: cell-free DNA test contingent on results from the combined test

Screening for trisomies 21 and 18 in a Spanish public hospital: from the combined test to the cell-free DNA test

Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10-11 weeks' gestation and the combined test at 11-13 weeks

Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy: update of The Fetal Medicine Foundation results and meta-analysis

The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled Trial

UK NHS pilot study on cell-free DNA testing in screening for fetal trisomies: factors affecting uptake.

Use of intrapartum ultrasound in the prediction of complicated operative forceps delivery of fetuses in non-occiput posterior position

Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y.